Skip to main content
. 2018 Feb 14;75(4):336–346. doi: 10.1001/jamapsychiatry.2017.4602

Table 2. Twelve-Month and Lifetime Prevalence of Other Psychiatric Disorders Among Those With DSM-5 MDDa.

Comorbid Psychiatric Disorder 12 mo Lifetime
Prevalence (SD)b aOR (95% CI)c Adjusted aOR (95% CI)d Prevalence (SD)b aOR (95% CI)c Adjusted aOR (95% CI)d
Any substance use disorder 45.3 (0.86) 2.0 (1.84-2.16) 1.4 (1.24-1.52) 57.9 (0.75) 2.2 (2.02-2.31) 1.5 (1.35-1.57)
Alcohol use disorder 22.2 (0.86) 1.8 (1.63-2.01) 1.2 (1.06-1.33) 40.8 (0.86) 2.0 (1.88-2.20) 1.3 (1.16-1.40)
Any drug use disorder 10.1 (0.57) 3.0 (2.57-3.55) 1.5 (1.20-1.79) 17.6 (0.65) 2.5 (2.21-2.78) 1.3 (1.14-1.49)
Nicotine use disorder 32.8 (0.94) 1.9 (1.69-2.07) 1.3 (1.12-1.41) 38.9 (0.83) 1.9 (1.75-2.02) 1.2 (1.12-1.34)
Any anxiety disorder 36.4 (0.96) 4.2 (3.81-4.57) 2.2 (1.94-2.44) 37.3 (0.70) 3.9 (3.57-4.17) 2.2 (2.05-2.43)
Panic 11.4 (0.59) 4.4 (3.73-5.25) 1.8 (1.45-2.21) 12.8 (0.53) 3.4 (3.05-3.89) 1.6 (1.40-1.86)
Agoraphobia 05.6 (0.44) 4.2 (3.28-5.27) 1.3 (1.05-1.70) 05.0 (0.33) 3.7 (3.04-4.54) 1.3 (1.07-1.64)
Social phobia 09.4 (0.64) 3.9 (3.32-4.66) 1.5 (1.19-1.76) 08.7 (0.46) 3.4 (2.95-3.86) 1.4 (1.22-1.61)
Specific phobia 11.6 (0.59) 2.1 (1.84-2.35) 1.0 (0.86-1.15) 12.2 (0.40) 2.3 (2.10-2.57) 1.3 (1.10-1.41)
Generalized anxiety disorder 19.9 (0.76) 5.7 (4.98-6.50) 2.4 (2.10-2.83) 20.5 (0.57) 4.9 (4.39- 5.47) 2.5 (2.18-2.78)
Posttraumatic stress disorder 16.3 (0.85) 4.4 (3.92-5.03) 1.8 (1.54-2.12) 15.6 (0.64) 4.1 (3.70-4.63) 1.9 (1.67-2.23)
Any personality disordere 40.9 (1.13) 4.6 (4.12-5.03) 2.4 (2.10-2.70) 31.9 (0.86) 3.9 (3.58-4.29) 2.0 (1.83-2.25)
Schizotypal 18.4 (0.94) 3.8 (3.33-4.30) 1.2 (1.04-1.46) 13.6 (0.68) 3.4 (2.90-3.88) 1.2 (1.03-1.47)
Borderline 35.7 (1.06) 5.2 (4.70-5.74) 2.6 (2.28-2.94) 26.6 (0.73) 4.4 (4.02-4.81) 2.2 (1.94-2.43)
Antisocial 08.4 (0.56) 2.3 (1.92-2.72) 0.9 (0.76-1.15) 07.4 (0.39) 2.5 (2.15-2.84) 1.2 (0.97-1.35)

Abbreviations: aOR, adjusted odds ratio; MDD, major depressive disorder.

a

The aORs indicate associations of MDD with other psychiatric disorders.

b

Prevalence of the given disorder among those with MDD in the corresponding time frame (eg, prevalence of 12-month disorders among those with 12-month MDD).

c

All aORs represent the odds of having a specific comorbid disorder among individuals with MDD relative to the odds of having specific comorbid disorder among individuals who do not have MDD. The aORs were adjusted for sex, race/ethnicity, age, marital status, educational level, family income, urbanicity, and region.

d

The aORs were adjusted for sex, race/ethnicity, age, marital status, educational level, family income, urbanicity, region, and psychiatric disorders other than bipolar I disorder.

e

Personality disorders assessed on a lifetime basis.